Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer

NCT01625702 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT01625702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01625702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2012
Completion date
December 31, 2015
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer